Log inStart free trialBook a demo
Log inStart free trial
Media Database
>
John Travis

John Travis

Managing Editor, News at Science

Contact this person
Email address
j*****@*******.orgGet email address
Influence score
46
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Biology/Microbiology
  • General Assignment News
  • Science

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

science.org

Nobel laureate will step down from leading embattled Salk Institute

Elizabeth Blackburn cuts short her tenure at Salk amid gender discrimination lawsuits, which have also led Inder Verma to take leave of absence from editor-in-chief of PNAS
about 4 years ago
science.org

An origin-al: Stanley Miller

In On the Origin of Life on Earth, the first of our monthly Origins essays, Carl Zimmer briefly notes Stanley Miller's
about 4 years ago
science.org

Meet Anthony Fauci, the epidemic expert trying to shape the White H...

The veteran government scientist has advised presidents for decades, but will the Trump administration listen to him now?
about 4 years ago
science.org

FDA just gave a thumbs down to Trump's favorite COVID-19 drugs

Agency withdraws emergency authorization for hydroxychloroquine and chloroquine
about 4 years ago
science.org

PETA Abandons $1 Million Prize for Artificial Chicken

Animal rights group declares contest a success despite no entries, shifts money to other causes
about 4 years ago
science.org

‘New era in digital biology’: AI reveals structures of nearly all k...

Advance from DeepMind’s AlphaFold software could revolutionize biology and medicine
over 3 years ago
science.org

NAS sanctions White House official, changes bylaws to allow member ...

Among other restrictions imposed by U.S. science academy, Jane Lubchenco barred from publishing in major journal for 5 years
over 3 years ago
science.org

Roche Alzheimer’s antibody fails to slow cognitive decline in major...

Results of phase 3 trials testing gantenerumab are latest blow to amyloid hypothesis
about 3 years ago
science.org

‘It’s not a miracle drug’: Eli Lilly’s antibody slows Alzheimer’s d...

First look at clinical trial data suggests donanemab may work better than similar-acting rival, but company acknowledges deaths and serious brain side effects
over 2 years ago
science.org

How a geneticist led the effort to free a mother convicted of killi...

“Science has been heard,” says Carola Vinuesa after Australia’s Kathleen Folbigg was pardoned and released from prison
over 2 years ago
science.org

This biologist aims to solve the cell’s biggest mystery. Could it h...

Four decades after his lab found odd, massive particles inside cells, Leonard Rome is still determined to figure out what “vaults” do
over 1 year ago